Trial Site Detail
Drug: |
BAY80-6946 + BAY86-9766 |
|||
|---|---|---|---|---|
Trial: |
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
University of Freiburg - Tumor Biology CenterBreisacher Straße 117 |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
University of Freiburg - Tumor Biology Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.